The steerable needle market size is projected to be worth US$ 1.09 billion in 2023. The market is likely to surpass US$ 2.13 billion by 2033 at a CAGR of 6.9% during the forecast period. With the global population aging rapidly, there is an increased demand for effective diagnostic and treatment solutions for age-related conditions. Steerable needles are advanced medical devices designed to enhance the precision and accuracy of needle-based procedures, such as biopsies, ablations, and drug delivery.
Other Drivers Propelling the Demand for Steerable Needle Market include:
Challenges for Companies /Manufacturers in the Steerable Needle Market:
Opportunities in the Steerable Needle Industry:
Latest Trends in the Steerable Needle Market:
| Attributes | Details |
|---|---|
| Steerable Needle Market Size (2023) | US$ 1.09 billion |
| Steerable Needle Market Projected Size (2033) | US$ 2.13 billion |
| Value CAGR (2023 to 2033) | 6.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global steerable needle market experienced a CAGR of 5.7%, reaching a market size of US$ 1.09 billion in 2023.
Worldwide, there is a significant shift toward minimally invasive procedures. Steerable needles allow practitioners to perform precise and targeted interventions while causing minimum tissue damage, reducing patient discomfort, and allowing for shorter recovery times. As a result, demand for steerable needles is projected to rise as medical professionals seek to provide patients with minimally invasive alternatives.
Personalized medicine, in which therapies are tailored to specific patients, is gaining popularity. Steerable needles enable targeted drug delivery and precise interventions based on individual patient characteristics. The demand for steerable needles is projected to rise as personalized treatment becomes more common.
Future Forecast for Steerable Needle Industry:
Looking ahead, the global steerable needle market is expected to rise at a CAGR of 6.9% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 2.13 billion by 2033.
The steerable needle market is seeing growth opportunities in developing regions such as Asia-Pacific and Latin America. These regions are undergoing tremendous economic development, as well as improvements in healthcare infrastructure and increased investments in healthcare technologies. Steerable needles are predicted to become more popular in these markets as access to modern medical technologies improves.
Steerable needles are in demand due to technological improvements such as robotic-assisted steering mechanisms, real-time imaging guiding, and sensor-enabled navigation systems. These developments improve the precision, accuracy, and safety of needle-based operations, resulting in increased utilization by healthcare practitioners.
| Country | The United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 676.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
The steerable needle market in the United States is expected to reach a market size of US$ 676.0 million by 2033, expanding at a CAGR of 7.0%. In the USA, the market expansion is fueled by factors such as the increasing adoption of minimally invasive procedures, a rising incidence of chronic diseases, advancements in needle technology, and a growing emphasis on personalized medicine. Also, the aging population and investments in healthcare infrastructure contribute to the market's growth.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 116.3 million |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The steerable needle market in the United Kingdom is expected to reach a market value of US$ 116.3 million, expanding at a CAGR of 7.2% during the forecast period. The market in the UK is expected to witness significant growth in the coming years. The UK's focus on healthcare advancements, investments in research and development, and the availability of advanced healthcare infrastructure contribute to the market's expansion. The market is poised to benefit from the increasing demand for precise and targeted interventions, driving the growth of the steerable needle market in the UK.
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 147.8 million |
| CAGR % 2023 to End of Forecast (2033) | 7.6% |
The steerable needle market in China is anticipated to reach a market size of US$ 147.8 million by the end of 2033, growing at a CAGR of 7.6% throughout the forecast period. With rising income levels and increased awareness of advanced healthcare technologies, the demand for precise and targeted interventions is growing in China. Patients are seeking high-quality medical treatments, leading to increased adoption of steerable needles by healthcare providers to meet the rising demand.
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 107.6 million |
| CAGR % 2023 to End of Forecast (2033) | 7.5% |
The steerable needle market in Japan is estimated to reach a market size of US$ 107.6 million by 2033, expected to thrive at a CAGR of 7.5%. Japan boasts a robust healthcare infrastructure, with well-equipped hospitals, research institutes, and skilled healthcare professionals. The presence of advanced healthcare facilities and a highly trained medical workforce supports the adoption of advanced medical devices like steerable needles. The strong healthcare infrastructure acts as a catalyst for market growth.
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 121.9 million |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The steerable needle market in South Korea is expected to reach a market size of US$ 121.9 million, expanding at a CAGR of 7.2% during the forecast period. South Korea has witnessed an increasing preference for minimally invasive procedures across various medical specialties. Steerable needles are essential tools in performing precise and targeted interventions with minimal tissue disruption, reduced patient discomfort, and faster recovery times. The rising demand for minimally invasive procedures has led to an increased adoption of steerable needles in the country.
Principal Consultant
Based on products, bevel-tip flexible needles dominated the category withholding the significant share of the market at around 38.9% at the end of 2022. Bevel-tip flexible needles are designed with a flexible shaft that allows for greater maneuverability and navigation through complex anatomical structures.
Over time, surgeons have become accustomed to using bevel-tip flexible needles due to their widespread availability and advantages. Familiarity and positive experiences with these needles lead to their continued adoption in the field.
Based on application, biopsy segment has led the category withholding about 24.5% of the total market share. Steerable needles enable a minimally invasive approach to biopsies. Compared to traditional open surgical procedures, steerable needles can be inserted through small incisions or even percutaneously, resulting in less tissue trauma, reduced scarring, shorter recovery times, and lower risks of complications.
The hospitals have led the steerable needle market as the leading end user with the market share of 59.4% in 2022. Hospitals are full-service medical facilities that offer a wide range of medical services, including diagnostic tests. They have the infrastructure, technology, and competence to provide a wide range of diagnostic tests, treatments and services, which demands the need for needles, including steerable needles.
The steerable needle market has undergone market consolidation, with key players establishing and vying to maintain their competitive edge. Key players in the steerable needle industry are using certain strategies to stay competitive, such as differentiating their offerings, and adapting to evolving market dynamics. Continuous innovation, strong partnerships, regulatory compliance, and strategic market expansion.
Key Strategies Used by the Participants
Key players continuously invest in research and development to introduce innovative products. They strive to develop assays with improved sensitivity, specificity, accuracy, and ease of use.
Key players often form strategic partnerships and collaborations with other companies, research institutions, and healthcare organizations. These partnerships can lead to knowledge sharing, joint product development, and expanded market reach.
Expanding into emerging markets with growing healthcare infrastructure and rising demand for steerable needles allows companies to tap into new opportunities and gain a competitive edge.
Companies in the market may engage in mergers or acquisitions to streamline their product portfolio, obtain new technologies, enter new market niches, and gain access to novel products or intellectual property.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Steerable Needle Market:
The steerable needle market is expected to progress at 6.9% CAGR until 2033.
The overall steerable needle market is projected to reach around US$ 2.13 billion by 2033.
Bevel-tip flexible needles made up for 38.9% market revenue in 2022.
China dominates the Asia Pacific market and is projected to advance at 7.6% CAGR through 2033.
Application steerable needles in biopsy segment captured almost 24.5% market share in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis, by Region
4.2. New Product Launches
4.3. Regulatory Landscape, by Country
4.4. PESTEL Analysis
4.5. Porter’s Five Force Analysis
4.6. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Surgical Needles Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing Minimally Invasive Surgical Procedures
5.2.2. Advancements in Robotics and Image-Guided Systems
5.2.3. Increasing Incidence of Chronic Diseases
5.2.4. Technological Innovations and Product Development
5.2.5. Growing Healthcare Expenditure
5.2.6. Frequency of Product Approvals
5.2.7. Consumption Rate
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
6.2. Historical Market Value (US$ Million) Analysis, 2017 to 2022
6.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
6.3.1. Y-o-Y Growth Trend Analysis
6.3.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Product, 2017 to 2022
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2023 to 2033
7.3.1. Bevel-Tip Flexible Needles
7.3.2. Symmetric-Tip Needles
7.3.3. Tendonactuated Tips
7.4. Market Attractiveness Analysis By Product
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
8.3.1. Biopsy
8.3.2. Tumor Ablation
8.3.3. Pain Management
8.3.4. Neurosurgery
8.3.5. Cardiac Interventions
8.3.6. Interventional Radiology
8.3.7. Robotic-Assisted Procedures
8.4. Market Attractiveness Analysis By Application
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis, By Region, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
11.3.1. By Country
11.3.1.1. USA
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By Application
11.4.4. By End User
11.5. Market Trends
11.6. Market Drivers & Restraints – Impact Analysis
11.7. Country Level Analysis & Forecast
11.7.1. USA Market
11.7.1.1. Introduction
11.7.1.2. Market Analysis and Forecast by Market Taxonomy
11.7.1.2.1. By Product
11.7.1.2.2. By Application
11.7.1.2.3. By End User
11.7.2. Canada Market
11.7.2.1. Introduction
11.7.2.2. Market Analysis and Forecast by Market Taxonomy
11.7.2.2.1. By Product
11.7.2.2.2. By Application
11.7.2.2.3. By End User
12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of LATAM
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Application
12.4.4. By End User
12.5. Market Trends
12.6. Market Drivers & Restraints – Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. Brazil Market
12.7.1.1. Introduction
12.7.1.2. Market Analysis and Forecast by Market Taxonomy
12.7.1.2.1. By Product
12.7.1.2.2. By Application
12.7.1.2.3. By End User
12.7.2. Mexico Market
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast by Market Taxonomy
12.7.2.2.1. By Product
12.7.2.2.2. By Application
12.7.2.2.3. By End User
12.7.3. Argentina Market
12.7.3.1. Introduction
12.7.3.2. Market Analysis and Forecast by Market Taxonomy
12.7.3.2.1. By Product
12.7.3.2.2. By Application
12.7.3.2.3. By End User
13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. UK
13.3.1.2. Germany
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Market Trends
13.6. Market Drivers & Restraints – Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. UK Market
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast by Market Taxonomy
13.7.1.2.1. By Product
13.7.1.2.2. By Application
13.7.1.2.3. By End User
13.7.2. Germany Market
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast by Market Taxonomy
13.7.2.2.1. By Product
13.7.2.2.2. By Application
13.7.2.2.3. By End User
13.7.3. France Market
13.7.3.1. Introduction
13.7.3.2. Market Analysis and Forecast by Market Taxonomy
13.7.3.2.1. By Product
13.7.3.2.2. By Application
13.7.3.2.3. By End User
13.7.4. Italy Market
13.7.4.1. Introduction
13.7.4.2. Market Analysis and Forecast by Market Taxonomy
13.7.4.2.1. By Product
13.7.4.2.2. By Application
13.7.4.2.3. By End User
13.7.5. Spain Market
13.7.5.1. Introduction
13.7.5.2. Market Analysis and Forecast by Market Taxonomy
13.7.5.2.1. By Product
13.7.5.2.2. By Application
13.7.5.2.3. By End User
13.7.6. BENELUX Market
13.7.6.1. Introduction
13.7.6.2. Market Analysis and Forecast by Market Taxonomy
13.7.6.2.1. By Product
13.7.6.2.2. By Application
13.7.6.2.3. By End User
13.7.7. Russia Market
13.7.7.1. Introduction
13.7.7.2. Market Analysis and Forecast by Market Taxonomy
13.7.7.2.1. By Product
13.7.7.2.2. By Application
13.7.7.2.3. By End User
14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Market Drivers & Restraints – Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. China Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By Application
14.7.1.2.3. By End User
14.7.2. Japan Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By Application
14.7.2.2.3. By End User
14.7.3. South Korea Market
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast by Market Taxonomy
14.7.3.2.1. By Product
14.7.3.2.2. By Application
14.7.3.2.3. By End User
15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Thailand
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Market Drivers & Restraints – Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. India Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By Application
15.7.1.2.3. By End User
15.7.2. Indonesia Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By Application
15.7.2.2.3. By End User
15.7.3. Thailand Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By Application
15.7.3.2.3. By End User
15.7.4. Malaysia Market
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast by Market Taxonomy
15.7.4.2.1. By Product
15.7.4.2.2. By Application
15.7.4.2.3. By End User
16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Market Drivers & Restraints – Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. Australia Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By Application
16.7.1.2.3. By End User
16.7.2. New Zealand Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By Application
16.7.2.2.3. By End User
17. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Türkiye
17.3.1.3. South Africa
17.3.1.4. Northern Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Market Drivers & Restraints – Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. GCC Countries Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Application
17.7.1.2.3. By End User
17.7.2. Türkiye Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Application
17.7.2.2.3. By End User
17.7.3. South Africa Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Product
17.7.3.2.2. By Application
17.7.3.2.3. By End User
17.7.4. Northern Africa Market
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Product
17.7.4.2.2. By Application
17.7.4.2.3. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Maternity Care Products)
18.2. Market Share Analysis of Top Players
18.3. Market Concentration
19. Competition Analysis
19.1. Competition Dashboard
19.2. Branding and Promotional Strategies, By key Players
19.3. Key Development Analysis
19.4. Competition Deep Dive
19.4.1. AprioMed
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Key Financials
19.4.1.4. SWOT Analysis
19.4.1.5. Key Developments
19.4.1.6. Sales Footprint
19.4.1.7. Strategy Overview
19.4.1.7.1. Marketing Strategy
19.4.1.7.2. Product Strategy
19.4.1.7.3. Channel Strategy
19.4.2. Elekta Instrument AB,
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Key Financials
19.4.2.4. SWOT Analysis
19.4.2.5. Key Developments
19.4.2.6. Sales Footprint
19.4.2.7. Strategy Overview
19.4.2.7.1. Marketing Strategy
19.4.2.7.2. Product Strategy
19.4.2.7.3. Channel Strategy
19.4.3. Medtronic
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Key Financials
19.4.3.4. SWOT Analysis
19.4.3.5. Key Developments
19.4.3.6. Sales Footprint
19.4.3.7. Strategy Overview
19.4.3.7.1. Marketing Strategy
19.4.3.7.2. Product Strategy
19.4.3.7.3. Channel Strategy
19.4.4. Boston Scientific
19.4.4.1. Overview
19.4.4.2. Product Portfolio
19.4.4.3. Key Financials
19.4.4.4. SWOT Analysis
19.4.4.5. Key Developments
19.4.4.6. Sales Footprint
19.4.4.7. Strategy Overview
19.4.4.7.1. Marketing Strategy
19.4.4.7.2. Product Strategy
19.4.4.7.3. Channel Strategy
19.4.5. Cook Medical
19.4.5.1. Overview
19.4.5.2. Product Portfolio
19.4.5.3. Key Financials
19.4.5.4. SWOT Analysis
19.4.5.5. Key Developments
19.4.5.6. Sales Footprint
19.4.5.7. Strategy Overview
19.4.5.7.1. Marketing Strategy
19.4.5.7.2. Product Strategy
19.4.5.7.3. Channel Strategy
19.4.6. Olympus Corporation
19.4.6.1. Overview
19.4.6.2. Product Portfolio
19.4.6.3. Key Financials
19.4.6.4. SWOT Analysis
19.4.6.5. Key Developments
19.4.6.6. Sales Footprint
19.4.6.7. Strategy Overview
19.4.6.7.1. Marketing Strategy
19.4.6.7.2. Product Strategy
19.4.6.7.3. Channel Strategy
19.4.7. Terumo Corporation
19.4.7.1. Overview
19.4.7.2. Product Portfolio
19.4.7.3. Key Financials
19.4.7.4. SWOT Analysis
19.4.7.5. Key Developments
19.4.7.6. Sales Footprint
19.4.7.7. Strategy Overview
19.4.7.7.1. Marketing Strategy
19.4.7.7.2. Product Strategy
19.4.7.7.3. Channel Strategy
19.4.8. Merit Medical Systems
19.4.8.1. Overview
19.4.8.2. Product Portfolio
19.4.8.3. Key Financials
19.4.8.4. SWOT Analysis
19.4.8.5. Key Developments
19.4.8.6. Sales Footprint
19.4.8.7. Strategy Overview
19.4.8.7.1. Marketing Strategy
19.4.8.7.2. Product Strategy
19.4.8.7.3. Channel Strategy
19.4.9. Vygon
19.4.9.1. Overview
19.4.9.2. Product Portfolio
19.4.9.3. Key Financials
19.4.9.4. SWOT Analysis
19.4.9.5. Key Developments
19.4.9.6. Sales Footprint
19.4.9.7. Strategy Overview
19.4.9.7.1. Marketing Strategy
19.4.9.7.2. Product Strategy
19.4.9.7.3. Channel Strategy
19.4.10. Johnson & Johnson
19.4.10.1. Overview
19.4.10.2. Product Portfolio
19.4.10.3. Key Financials
19.4.10.4. SWOT Analysis
19.4.10.5. Key Developments
19.4.10.6. Sales Footprint
19.4.10.7. Strategy Overview
19.4.10.7.1. Marketing Strategy
19.4.10.7.2. Product Strategy
19.4.10.7.3. Channel Strategy
19.4.11. B. Braun Melsungen AG
19.4.11.1. Overview
19.4.11.2. Product Portfolio
19.4.11.3. Key Financials
19.4.11.4. SWOT Analysis
19.4.11.5. Key Developments
19.4.11.6. Sales Footprint
19.4.11.7. Strategy Overview
19.4.11.7.1. Marketing Strategy
19.4.11.7.2. Product Strategy
19.4.11.7.3. Channel Strategy
19.4.12. Stryker Corporation
19.4.12.1. Overview
19.4.12.2. Product Portfolio
19.4.12.3. Key Financials
19.4.12.4. SWOT Analysis
19.4.12.5. Key Developments
19.4.12.6. Sales Footprint
19.4.12.7. Strategy Overview
19.4.12.7.1. Marketing Strategy
19.4.12.7.2. Product Strategy
19.4.12.7.3. Channel Strategy
19.4.13. Smith & Nephew
19.4.13.1. Overview
19.4.13.2. Product Portfolio
19.4.13.3. Key Financials
19.4.13.4. SWOT Analysis
19.4.13.5. Key Developments
19.4.13.6. Sales Footprint
19.4.13.7. Strategy Overview
19.4.13.7.1. Marketing Strategy
19.4.13.7.2. Product Strategy
19.4.13.7.3. Channel Strategy
19.4.14. AngioDynamics Inc.
19.4.14.1. Overview
19.4.14.2. Product Portfolio
19.4.14.3. Key Financials
19.4.14.4. SWOT Analysis
19.4.14.5. Key Developments
19.4.14.6. Sales Footprint
19.4.14.7. Strategy Overview
19.4.14.7.1. Marketing Strategy
19.4.14.7.2. Product Strategy
19.4.14.7.3. Channel Strategy
19.4.15. Teleflex Incorporated
19.4.15.1. Overview
19.4.15.2. Product Portfolio
19.4.15.3. Key Financials
19.4.15.4. SWOT Analysis
19.4.15.5. Key Developments
19.4.15.6. Sales Footprint
19.4.15.7. Strategy Overview
19.4.15.7.1. Marketing Strategy
19.4.15.7.2. Product Strategy
19.4.15.7.3. Channel Strategy
19.4.16. Argon Medical Devices Inc.
19.4.16.1. Overview
19.4.16.2. Product Portfolio
19.4.16.3. Key Financials
19.4.16.4. SWOT Analysis
19.4.16.5. Key Developments
19.4.16.6. Sales Footprint
19.4.16.7. Strategy Overview
19.4.16.7.1. Marketing Strategy
19.4.16.7.2. Product Strategy
19.4.16.7.3. Channel Strategy
19.4.17. BD (Becton, Dickinson and Company)
19.4.17.1. Overview
19.4.17.2. Product Portfolio
19.4.17.3. Key Financials
19.4.17.4. SWOT Analysis
19.4.17.5. Key Developments
19.4.17.6. Sales Footprint
19.4.17.7. Strategy Overview
19.4.17.7.1. Marketing Strategy
19.4.17.7.2. Product Strategy
19.4.17.7.3. Channel Strategy
19.4.18. Cardinal Health Inc.
19.4.18.1. Overview
19.4.18.2. Product Portfolio
19.4.18.3. Key Financials
19.4.18.4. SWOT Analysis
19.4.18.5. Key Developments
19.4.18.6. Sales Footprint
19.4.18.7. Strategy Overview
19.4.18.7.1. Marketing Strategy
19.4.18.7.2. Product Strategy
19.4.18.7.3. Channel Strategy
19.4.19. Teleflex Medical OEM
19.4.19.1. Overview
19.4.19.2. Product Portfolio
19.4.19.3. Key Financials
19.4.19.4. SWOT Analysis
19.4.19.5. Key Developments
19.4.19.6. Sales Footprint
19.4.19.7. Strategy Overview
19.4.19.7.1. Marketing Strategy
19.4.19.7.2. Product Strategy
19.4.19.7.3. Channel Strategy
19.4.20. ConMed Corporation
19.4.20.1. Overview
19.4.20.2. Product Portfolio
19.4.20.3. Key Financials
19.4.20.4. SWOT Analysis
19.4.20.5. Key Developments
19.4.20.6. Sales Footprint
19.4.20.7. Strategy Overview
19.4.20.7.1. Marketing Strategy
19.4.20.7.2. Product Strategy
19.4.20.7.3. Channel Strategy
19.4.21. Mindray Medical International Limited
19.4.21.1. Overview
19.4.21.2. Product Portfolio
19.4.21.3. Key Financials
19.4.21.4. SWOT Analysis
19.4.21.5. Key Developments
19.4.21.6. Sales Footprint
19.4.21.7. Strategy Overview
19.4.21.7.1. Marketing Strategy
19.4.21.7.2. Product Strategy
19.4.21.7.3. Channel Strategy
19.4.22. Hologic Inc.
19.4.22.1. Overview
19.4.22.2. Product Portfolio
19.4.22.3. Key Financials
19.4.22.4. SWOT Analysis
19.4.22.5. Key Developments
19.4.22.6. Sales Footprint
19.4.22.7. Strategy Overview
19.4.22.7.1. Marketing Strategy
19.4.22.7.2. Product Strategy
19.4.22.7.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Steerable Needle Market
